By Teresa Carr
Within the coming yr, President Donald Trump’s administration will face a alternative: Spend billions of {dollars} to cowl anti-obesity medication below Medicare and Medicaid, or deny greater than 7 million individuals entry to a doubtlessly lifesaving therapy. The choice represents an inflection level in how the U.S. pays for well being care. What occurs when thousands and thousands of People stand to learn from an revolutionary therapy, but it surely’s priced so excessive that the majority can’t afford it?
The latest era of anti-obesity drugs — Saxenda (liraglutide), Wegovy (semaglutide), and Zepbound (tirzepatide) — belong to a class of medicine generally known as GLP-1 agonists, or GLP-1s. Their effectiveness towards diabetes, weight problems, coronary heart illness, sleep apnea, and a rising record of different situations has rocketed the medication to blockbuster standing: One in eight U.S. adults has taken a GLP-1 drug, in response to a Might 2024 ballot carried out by the nonprofit well being coverage group KFF.
However many individuals can’t afford them. At the least partly resulting from their excessive price — for instance, annual record worth for Wegovy is round $16,000 or extra — Medicare in addition to most state Medicaid plans have solely coated the medication for diabetes. Personal insurers are additionally battling the prices. Final yr, solely round one in 5 giant U.S. corporations coated GLP-1s for weight reduction of their well being plans, in response to outcomes from a KFF survey revealed final October within the journal Well being Affairs.
Modifications in protection can have massive results on budgets. Final spring, the Facilities for Medicare and Medicaid Providers opted to cowl Wegovy for individuals with coronary heart illness who’re additionally obese or overweight with out diabetes. That call will add $10 billion to annual Medicare spending, in response to essentially the most conservative estimate from a current evaluation revealed within the Annals of Inner Medication.
And if the Trump administration upholds a proposal from former President Joe Biden’s administration to additional lengthen GLP-1 protection for weight problems alone? That will undoubtedly add billions to federal and state spending, mentioned the lead writer of the Annals of Inner Medication examine, Alexander Chaitoff, an internist and well being coverage researcher on the College of Michigan.
“At current prices, it would be incredibly difficult to pay for these drugs and get them to all of the people that would likely want to use them,” mentioned Chaitoff.
Some well being coverage specialists contend that broader protection will enrich drug corporations with out essentially making People more healthy.
To keep up weight reduction, individuals may have to remain on GLP-1s indefinitely, and the long-term dangers are unsure, mentioned Scott Atlas, a well being care coverage knowledgeable on the Hoover Establishment, a conservative assume tank at Stanford College, and a medical adviser in the course of the first Trump administration. “We’re playing with fire here, and it’s a rush to demand insurance.”
“At present costs, it might be extremely tough to pay for these medication and get them to all the individuals that might possible wish to use them.”
Nevertheless, a number of main medical organizations help GLP-1 therapy for weight problems. A kind of teams, the American Medical Affiliation, has even urged insurers to cowl the drugs.
Now, a rising refrain of advocates are calling on legislators to unravel the price-access conundrum by, partly, strong-arming drug makers into reducing costs. It’s unfair that Novo Nordisk costs much more for Wegovy within the U.S. than in different nations, wrote 253 members of the nonprofit advocacy group Medical doctors for America in a letter submitted to a U.S. Senate listening to on GLP-1 pricing final September. A month’s value of Wegovy, which lists for $1,348 within the U.S., prices $186 in Denmark, the group identified, and simply $92 in the UK.
“Senators,” they implored, “we are asking you to do everything in your power to bring down the price of these novel diabetes and obesity drugs.”
One of many signatories of the Medical doctors for America letter was Reshma Ramachandran, a Yale College well being researcher and household doctor who treats underserved populations. Her sufferers are affected by continual situations resembling diabetes, coronary heart illness, and weight problems, she mentioned. And one of many obstacles standing between them and efficient therapy with GLP-1s, she added, is constant insurance coverage protection for the medication: “The medications are incredibly hard to access.”
Ramchandran mentioned that she has to leap via hoops to attempt to persuade insurers to cowl the costly medication even for sufferers who might clearly profit, like these with diabetes or who’re obese and have heart problems. And even then, she mentioned that she shouldn’t be all the time profitable.
Cheaper compounded variations of GLP-1s are nonetheless too costly for many of her sufferers, mentioned Ramachandran. (These compounded GLP-1s, that are created in pharmacies, usually are not FDA-approved, and the company has repeatedly warned about issues with some formulations.)
The best purpose drug makers cost a lot within the U.S., mentioned Ramachandran, is as a result of they’ll. In contrast to in different nations, she mentioned, there’s no mechanism within the U.S. to barter the launch worth of a brand new drug, which means that drug corporations can set the preliminary worth as excessive because the market will bear.
Because of patents and intervals of exclusivity granted by the Meals and Drug Administration, the makers of recent medication take pleasure in years of entry to the market earlier than generic makers are legally allowed to make an unbranded model. A 2023 evaluation revealed within the Journal of the American Medical Affiliation discovered that, on common, GLP-1s are protected against generic opponents for 18 years after FDA approval.
Throughout that window with out competitors, drug makers set record costs excessive, understanding that they are going to web considerably much less after middleman corporations referred to as pharmacy profit managers, or PBMs, negotiate rebates and reductions for the insurance coverage packages that they symbolize.
For instance, analysis suggests Novo Nordisk nets about $700 for a month’s value of Wegovy, simply over half the record worth.
Even that worth, information suggests, represents an enormous markup.
Factoring within the prices of manufacturing, logistics, and taxes, Novo Nordisk might promote injectable semaglutide (bought as Wegovy for weight reduction and Ozempic for diabetes) for lower than $5 per 30 days and nonetheless make a 50 % revenue, in response to a 2024 evaluation in JAMA Community Open that was funded by Entry Marketing campaign of Medical doctors With out Borders, a nonprofit medical support group.
“I’m grateful that it wasn’t my first rodeo,” mentioned the examine’s lead writer, Melissa Barber, a Yale College of Medication well being economist who has estimated the manufacturing prices of hundreds of medicine. In any other case, she mentioned, “people wouldn’t have believed me because the results were so appalling.”
Novo Nordisk might promote Wegovy for lower than $5 per 30 days and nonetheless make a 50 % revenue, in response to a 2024 evaluation
The price estimate by Barber and colleagues is a “misleading oversimplification,” Novo Nordisk spokesman David McAlpine wrote in an e-mail. “By the authors’ own admission, their model ignores the cost of creating something out of nothing and bringing it to market,” he wrote, noting that the corporate spent $10 billion growing GLP-1s and greater than $30 billion within the final yr on increasing manufacturing.
In written testimony submitted to the September Senate listening to, Novo Nordisk CEO Lars Fruergaard Jørgensen justified the corporate’s U.S. pricing primarily based on these improvement and analysis prices and the worth to sufferers. Ramachandran scoffed at that concept. The merchandise have been available on the market lengthy sufficient that the corporate has already made tens of billions of {dollars}, she mentioned: “They’ve gotten their return on investment and then some.”
For his half, Jørgensen positioned the blame for prime U.S. drug costs squarely on PBMs. As a result of the PBMs obtain charges primarily based on a share of a drug’s record worth, they favor costlier medication, he testified within the listening to. “Which means that in our experience, products that come with a low list price get less coverage,” mentioned Jørgensen. “It’s less attractive.”
In the meantime, Sen. Bernie Sanders of Vermont advised the committee that he had commitments in writing from the key PBMs that they might not restrict entry to Wegovy or Ozempic if Novo Nordisk lowered its costs.
The plain answer to the affordability disaster, in response to Ramachandran and others, is for drug makers to cost much less. However aside from shaming pharmaceutical executives in a public discussion board, lawmakers have few choices for controlling drug pricing.
In an op-ed for the well being information web site STAT, Ramachandran, Barber, and first care doctor and well being coverage analysis Joseph S. Ross facetiously counsel that it might be cheaper in the long term for the federal authorities to easily purchase Novo Nordisk for its market worth of $606 billion than to pay the corporate for its merchandise.
Barring shopping for the corporate outright, the U.S. authorities might purchase the license for Wegovy, the researchers prompt, after which grant the rights to a different firm to make a less expensive generic. The CEOs of main generic pharmaceutical corporations mentioned that they might market generic semaglutide for lower than $100 month, in response to remarks by Sanders within the Senate listening to. As it’s, generic maker’s arms are tied till the patents for semaglutide merchandise expire. (In keeping with Novo Nordisk’s 2023 annual report, the patent for Ozempic expires in 2032.)
Nevertheless, with doubtlessly higher remedies on the horizon, pre-empting the market shouldn’t be a good suggestion, mentioned Joseph Levy, a well being economist at Johns Hopkins College. “What that would mean is that the government was choosing a winner here,” he mentioned. “There’s probably going to be incremental improvements over time in the quality of these drugs, whether they have more weight loss effects or possibly less adverse events and side effects.”
In its closing week, the Biden administration added three GLP-1s, together with Wegovy, to the record of medicines coated by Medicare that the federal authorities is allowed to haggle over. A number of specialists advised Undark that these negotiations symbolize a sensible path to reducing prices.
“How they choose to set that price will be extraordinarily important for medium term-to-longer-term costs,” mentioned Benedic Ippolito, a well being economist on the American Enterprise Institute, a right-leaning public coverage assume tank. If Wegovy prices much less, then opponents will even have to chop their costs.
Aside from shaming pharmaceutical executives in a public discussion board, lawmakers have few choices for controlling drug pricing.
However these decrease costs, scheduled to take impact in 2027, could not spill over into the non-public insurance coverage market, Ippolito wrote in an e-mail. “I expect that Medicare negotiation will have minimal effects on prices in the commercial market,” he wrote.
Ramachandran disagrees. The large insurance coverage corporations, that are additionally concerned in managing Medicare Benefit and a few Medicaid plans, typically have a look at the Medicare costs as a place to begin for their very own negotiations, she mentioned.
Even when the federal government takes no motion, market forces will ultimately carry costs down, mentioned Levy. Whereas the record costs for GLP-1 have remained stubbornly excessive, the web costs have come down as aggressive merchandise entered the market, he mentioned.
Atlas, the Stanford well being economist, sees a potential delay in widespread entry to GLP-1s as a possibility. He’d reasonably see assets invested in a public well being initiative targeted on the well being dangers of weight problems alongside the strains of anti-smoking campaigns. “It’s embarrassing as a medical scientist to hear people ignoring all that and now rushing to a drug,” he mentioned.
Well being professionals ought to emphasize nondrug approaches to combatting weight problems, mentioned Atlas, and “it can be fixed or modified or lessened — the studies are there — by diet, by exercise, by education.”
That imaginative and prescient runs counter to the official pointers of the American Gastroenterological Society, which concludes that many individuals simply aren’t capable of shed kilos via way of life adjustments. The Society’s specialists analyzed six scientific trials that adopted contributors for a yr or longer whereas they tried to shed pounds both via a mixture of weight-reduction plan, train, and drugs, or via way of life adjustments alone. General, 30 % of the diet-and-exercise group misplaced 5 % or extra of their physique weight, in comparison with about 80 % who additionally took a GLP-1.
Nonetheless, Atlas want to know extra concerning the longer-term results of GLP-1s earlier than they’re prescribed to a big swath of People. Suspending protection would purchase time to conduct much-need security research, he mentioned. “I prefer the idea of being very cautious here, being conservative in terms of developing drugs, doing safety studies, doing efficacy studies, doing other measures that are completely non-hazardous,” he added. “And in the meantime, letting drug manufacturers start competing.”
For the thousands and thousands of People with weight problems who’re on Medicare and Medicaid the best means to enhance entry to GLP-1s can be for these packages to offer full protection. Whether or not that’s possible at present costs, although, stays a subject of debate.
Levy and Ippolito, the worth analysts, mentioned that many scientific publications and reviews within the press have overestimated the associated fee to Medicare. “People were just kind of taking the list price of the drug and multiplying it by estimates of how many obese people there are,” mentioned Levy, “and say ‘This is going to bankrupt the federal government’.”
In the actual world, insurers typically pay lower than the record worth. And solely a fraction of eligible sufferers winds up taking GLP-1s long run, mentioned Levy. Plus, if sufferers are profitable in losing a few pounds, which may lead to well being advantages that save the system cash. Accounting for these elements, Levy and Ippolito revealed what they think about a sensible evaluation of the Medicare prices to cowl GLP-1s for weight problems in Well being Affairs final September. If, because the Facilities for Medicare and Medicaid Providers, or CMS, anticipates, 10 % of eligible Medicare sufferers obtain the drug, the economists estimate that half D drug plan prices would enhance by greater than $6 billion every year.
A staggering sum, even when it’s lower than many individuals anticipated, mentioned Ippolito. “It’s extraordinarily weird to me to be in a position of saying some incremental policy change is going to affect spending by tens of billions of dollars over a budget window and people being like, ‘that’s it?’” he mentioned. “That’s kind of a lot.”
“I prefer the idea of being very cautious here, being conservative in terms of developing drugs, doing safety studies, doing efficacy studies, doing other measures that are completely non-hazardous.”
If private and non-private insurers broaden GLP-1 protection, everyone seems to be prone to really feel the influence, mentioned Chaitoff. “Eventually we pay the price for it,” he mentioned. “If these medications are costing a lot and insurers are paying for it now, in the next year, or the next year, eventually that goes into your premium.”
As well as, GLP-1 expenditures could displace funding for remedies resembling train packages and dietary counseling. Whereas Barber favors increasing entry to GLP-1s, the associated fee will inevitably eat into funding for different providers, she mentioned. “I wish people were talking more about the trade-offs,” she added. “If Medicare funds this, what can’t it fund?”
Whether or not the Trump administration would require Medicare and Medicaid to cowl anti-obesity medication stays an open query, as distinguished Republican advisers disagree on the perfect methods to “make America healthy again.”
In an October interview with Fox Information, Robert F. Kennedy, President Donald Trump’s choose for well being secretary, decried each the utility and price of GLP-1s, which he pegged as $3 trillion yearly — a extensively inflated quantity he appears to have calculated by multiplying a too-high record worth by the variety of obese People. “They’re counting on selling it to Americans because we are so stupid and so addicted to drugs,” Kennedy mentioned.
However by his January affirmation listening to earlier than a U.S. Senate committee, Kennedy appeared to have softened his stance, referring to GLP-1s as “miracle drugs” — though he warned that protecting GLP-1s for all People who’re obese would result in a “tsunami” of prices for federal and business insurers.
In the meantime, Mehmet Oz, who Trump has nominated to steer CMS, promoted GLP-1s on his web site and ran prolonged infomercials sponsored by Novo Nordisk on his eponymous tv present, in response to reporting from The Washington Publish.
And know-how titan and Trump adviser Elon Musk, who referred to himself as “Ozempic Santa” in a December submit on his social media website X, is a powerful proponent of accelerating entry to GLP-1s. “Nothing would do more to improve the health, lifespan and quality of life for Americans than making GLP inhibitors super low cost to the public,” Musk posted on X.
Atlas, who has suggested a number of Republican presidential candidates along with Trump, mentioned that he’d wish to see the incoming administration shoot down the proposal to broaden GLP-1 protection. “But I’m worried that they will lack political courage to say, ‘no, these drugs should not be covered by insurance at this point unless there’s an extraordinary clinical indication,” he mentioned.
Ippolito is much less sanguine concerning the destiny of the proposed growth: “I would not be surprised if they rescinded this policy both on the grounds that they don’t like the policy itself and on the grounds that they think it might be an overreach of legal authority.” By legislation, Medicare is prohibited from paying for weight-loss medication. Whereas GLP-1s symbolize an weight problems therapy and usually are not supposed for beauty weight reduction, except Congress explicitly overturns the ban, protection might nonetheless be topic to authorized problem.
Restrictions on entry to costly medication are like making use of a Band-Help to a deeply dysfunctional system, one knowledgeable mentioned — one which staunches monetary bleeding by denying important remedies.
Nonetheless, as GLP-1s are inevitably FDA-approved for extra indications and costs come down, the price range math for protecting weight problems therapy via Medicare and Medicaid will begin to look extra favorable to regulators, mentioned Ippolito: “My guess is that they will eventually cover these within the next, say, five years or so.”
Personal insurers are additionally prone to broaden GLP-1 protection within the subsequent few years, Ippolito wrote in a follow-up e-mail, though the associated fee could also be mirrored in increased premiums. Industrial markets aren’t prone to notice an enormous drop in GLP-1 pricing till the early 2030s, when generic makers are prone to enter the market, he wrote.
Comparable circumstances spotlight how these delays might price lives. Barber recalled the case of the drug Sovaldi (sofosbuvir), a therapy for hepatitis C that price $84,000 when it was authorised in 2013: “It was a very, very effective drug for a very, very deadly disease.” However, as a result of expense, many state Medicaid packages initially restricted entry to the lifesaving drug.
Restrictions on entry to costly medication are like making use of a Band-Help to a deeply dysfunctional system, mentioned Barber — one which staunches monetary bleeding by denying important remedies. “But because this drug is so astronomically expensive and potentially so many people are eligible for it,” she mentioned, “it really forces us to deal with the kind of systemic flaws that we tried to paper over.”
This text was initially revealed on Undark. Learn the unique article.
—
Beforehand Printed on undark.org
***
Does relationship ever really feel difficult, awkward or irritating?
Flip Your Relationship Life right into a WOW! with our new lessons and reside teaching.
Click on right here for more information or to purchase with particular launch pricing!
***
On Substack? Observe us there for extra nice relationship and relationships content material.
Be part of The Good Males Challenge as a Premium Member right now.
All Premium Members get to view The Good Males Challenge with NO ADS. Want extra information? A whole record of advantages is right here.
—
Photograph credit score: iStock
The submit For Many, Weight-Loss Medication Are Dear. Increasing Entry Is Laborious. appeared first on The Good Males Challenge.
Success Tales
ADVERTISEMENT:
Informasi mengenai KING SLOT, Segera Daftar Bersama king selot terbaik dan terpercaya no satu di Indonesia. Boleh mendaftar melalui sini king slot serta memberikan hasil kembali yang paling tinggi saat sekarang ini hanyalah KING SLOT paling gacor, gilak dan gaco saat sekarang di Indonesia melalui program return tinggi di kingselot serta pg king slot
adu88 permainan paling high dan garansi imbal balik hasil besar bersama https://adu88.asia/
agoda88 permainan paling high dan garansi imbal balik hasil besar bersama https://agoda88.asia/
aryaduta88 permainan paling high dan garansi imbal balik hasil besar bersama https://aryaduta88.com/
bajaringan permainan paling high dan garansi imbal balik hasil besar bersama https://bajaringan.asia/
bangkit88 permainan paling high dan garansi imbal balik hasil besar bersama https://bangkit88.biz/
https://basket88.web/
batu88 permainan paling high dan garansi imbal balik hasil besar bersama https://batu88.biz/
berita88 permainan paling high dan garansi imbal balik hasil besar bersama https://berita88.biz/
best88 permainan paling high dan garansi imbal balik hasil besar bersama https://best88.asia/
booking88 permainan paling high dan garansi imbal balik hasil besar bersama https://booking88.org/
ceria88 permainan paling high dan garansi imbal balik hasil besar bersama https://ceria88.biz/
cipit888 permainan paling high dan garansi imbal balik hasil besar bersama https://cipit888.asia/
dinojp88 permainan paling high dan garansi imbal balik hasil besar bersama https://dinojp88.com/
dosen88 permainan paling high dan garansi imbal balik hasil besar bersama https://dosen88.org/
eyangslot88 permainan paling high dan garansi imbal balik hasil besar bersama https://eyangslot88.biz/
f88bet permainan paling high dan garansi imbal balik hasil besar bersama https://f88bet.asia/
forwin777 permainan paling high dan garansi imbal balik hasil besar bersama https://forwin777.biz/
gacoan888 permainan paling high dan garansi imbal balik hasil besar bersama https://gacoan888.biz/
gacor666 permainan paling high dan garansi imbal balik hasil besar bersama https://gacor666.biz/
gambar88 permainan paling high dan garansi imbal balik hasil besar bersama https://gambar88.org/
gemoy888slot permainan paling high dan garansi imbal balik hasil besar bersama https://gemoy888slot.information/
gercep888 permainan paling high dan garansi imbal balik hasil besar bersama https://gercep888.asia/
gitar88 permainan paling high dan garansi imbal balik hasil besar bersama https://gitar88.asia/
gmail88 permainan paling high dan garansi imbal balik hasil besar bersama https://gmail88.org/
grandaston88 permainan paling high dan garansi imbal balik hasil besar bersama https://grandaston88.com/
grandmercure88 permainan paling high dan garansi imbal balik hasil besar bersama https://grandmercure88.com/
hermes88 permainan paling high dan garansi imbal balik hasil besar bersama https://hermes88.biz/
heroslot888 permainan paling high dan garansi imbal balik hasil besar bersama https://heroslot888.information/
hoki222 permainan paling high dan garansi imbal balik hasil besar bersama https://hoki222.biz/
holidayinn88 permainan paling high dan garansi imbal balik hasil besar bersama https://holidayinn88.com/
hotelharis88 permainan paling high dan garansi imbal balik hasil besar bersama https://hotelharis88.com/
ibis88 permainan paling high dan garansi imbal balik hasil besar bersama https://ibis88.asia/
ibisbudget88 permainan paling high dan garansi imbal balik hasil besar bersama https://ibisbudget88.com/
indonesia88 permainan paling high dan garansi imbal balik hasil besar bersama https://indonesia88.information/
inspirasi permainan paling high dan garansi imbal balik hasil besar bersama https://inspirasi.information/
janjigacor88 permainan paling high dan garansi imbal balik hasil besar bersama https://janjigacor88.org/
jitujp88 permainan paling high dan garansi imbal balik hasil besar bersama https://jitujp88.com/
jokiwin88 permainan paling high dan garansi imbal balik hasil besar bersama https://jokiwin88.web/
juragan66 permainan paling high dan garansi imbal balik hasil besar bersama https://juragan66.biz/
jwmarriott88 permainan paling high dan garansi imbal balik hasil besar bersama https://jwmarriott88.com/
kedai88slot permainan paling high dan garansi imbal balik hasil besar bersama https://kedai88slot.biz/
kilau88 permainan paling high dan garansi imbal balik hasil besar bersama https://kilau88.biz/
kimjongun permainan paling high dan garansi imbal balik hasil besar bersama https://kimjongun.asia/
kiw88 permainan paling high dan garansi imbal balik hasil besar bersama https://kiw88.biz/
koi777 permainan paling high dan garansi imbal balik hasil besar bersama https://koi777.biz/
kucing permainan paling high dan garansi imbal balik hasil besar bersama https://kucing.information/
kudaslot88slot permainan paling high dan garansi imbal balik hasil besar bersama https://kudaslot88slot.com/
kuncigitar permainan paling high dan garansi imbal balik hasil besar bersama https://kuncigitar.org/
kuta88 permainan paling high dan garansi imbal balik hasil besar bersama https://kuta88.asia/
madu888slot permainan paling high dan garansi imbal balik hasil besar bersama https://madu888slot.web/
maniaslot88 permainan paling high dan garansi imbal balik hasil besar bersama https://maniaslot88.professional/
maxbet888slot permainan paling high dan garansi imbal balik hasil besar bersama https://maxbet888slot.com/
mercure88 permainan paling high dan garansi imbal balik hasil besar bersama https://mercure88.com/
mitra777slot permainan paling high dan garansi imbal balik hasil besar bersama https://mitra777slot.biz/
mobilelegends88 permainan paling high dan garansi imbal balik hasil besar bersama https://mobilelegends88.com/
moris88 permainan paling high dan garansi imbal balik hasil besar bersama https://moris88.org/
motivasi88 permainan paling high dan garansi imbal balik hasil besar bersama https://motivasi88.com/
nagacc88 permainan paling high dan garansi imbal balik hasil besar bersama https://nagacc88.com/
nasigoreng88 permainan paling high dan garansi imbal balik hasil besar bersama https://nasigoreng88.com/
neng88 permainan paling high dan garansi imbal balik hasil besar bersama https://neng88.biz/
neototo88 permainan paling high dan garansi imbal balik hasil besar bersama https://neototo88.com/
newslot888 permainan paling high dan garansi imbal balik hasil besar bersama https://newslot888.biz/
ngopibet88 permainan paling high dan garansi imbal balik hasil besar bersama https://ngopibet88.org/
nibung888 permainan paling high dan garansi imbal balik hasil besar bersama https://nibung888.biz/
nonstop888slot permainan paling high dan garansi imbal balik hasil besar bersama https://nonstop888slot.com/
nova12 permainan paling high dan garansi imbal balik hasil besar bersama https://nova12.web/
novotel88 permainan paling high dan garansi imbal balik hasil besar bersama https://novotel88.com/
oli88 permainan paling high dan garansi imbal balik hasil besar bersama https://oli88.org/
omset88 permainan paling high dan garansi imbal balik hasil besar bersama https://omset88.com/
orientalplay88 permainan paling high dan garansi imbal balik hasil besar bersama https://orientalplay88.com/
oxwin88 permainan paling high dan garansi imbal balik hasil besar bersama https://oxwin88.com/
oyo88 permainan paling high dan garansi imbal balik hasil besar bersama https://oyo88.reside/
pahala88 permainan paling high dan garansi imbal balik hasil besar bersama https://pahala88.biz/
paris777slot permainan paling high dan garansi imbal balik hasil besar bersama https://paris777slot.biz/
parsel88 permainan paling high dan garansi imbal balik hasil besar bersama https://parsel88.com/
pesiarbet88slot permainan paling high dan garansi imbal balik hasil besar bersama https://pesiarbet88slot.web/
pizzahut88 permainan paling high dan garansi imbal balik hasil besar bersama https://pizzahut88.web/
planet777slot permainan paling high dan garansi imbal balik hasil besar bersama https://planet777slot.biz/
pmg888 permainan paling high dan garansi imbal balik hasil besar bersama https://pmg888.biz/
pohon88 permainan paling high dan garansi imbal balik hasil besar bersama https://pohon88.biz/
polaris888 permainan paling high dan garansi imbal balik hasil besar bersama https://polaris888.information/
prediksi88 permainan paling high dan garansi imbal balik hasil besar bersama https://prediksi88.biz/
puas88 permainan paling high dan garansi imbal balik hasil besar bersama https://puas88.com/
pubg88 permainan paling high dan garansi imbal balik hasil besar bersama https://pubg88.information/
pulaujudi88 permainan paling high dan garansi imbal balik hasil besar bersama https://pulaujudi88.information/
puma888 permainan paling high dan garansi imbal balik hasil besar bersama https://puma888.information/
pusakajitu88 permainan paling high dan garansi imbal balik hasil besar bersama https://pusakajitu88.com/
qqhok88 permainan paling high dan garansi imbal balik hasil besar bersama https://qqhok88.org/
quiz88 permainan paling high dan garansi imbal balik hasil besar bersama https://quiz88.biz/
quiz88slot permainan paling high dan garansi imbal balik hasil besar bersama https://quiz88slot.com/
rajah permainan paling high dan garansi imbal balik hasil besar bersama https://rajah.asia/
reddoorz88 permainan paling high dan garansi imbal balik hasil besar bersama https://reddoorz88.com/
registrasi88 permainan paling high dan garansi imbal balik hasil besar bersama https://registrasi88.com/
ribut88 permainan paling high dan garansi imbal balik hasil besar bersama https://ribut88.web/
roblox88 permainan paling high dan garansi imbal balik hasil besar bersama https://roblox88.org/
rockygerung88 permainan paling high dan garansi imbal balik hasil besar bersama https://rockygerung88.com/
rumah permainan paling high dan garansi imbal balik hasil besar bersama https://rumah.asia/
microvip888 permainan paling high dan garansi imbal balik hasil besar bersama https://microvip888.com
slot demo gacor permainan paling high dan garansi imbal balik hasil besar bersama https://kdwapp.com/
akun demo slot gacor permainan paling high dan garansi imbal balik hasil besar bersama https://kdwapp.com/
akun slot demo gacor permainan paling high dan garansi imbal balik hasil besar bersama https://kdwapp.com/
akun demo slot pragmatic permainan paling high dan garansi imbal balik hasil besar bersama https://kdwapp.com/
akun slot demo pragmatic permainan paling high dan garansi imbal balik hasil besar bersama https://kdwapp.com/
akun slot demo permainan paling high dan garansi imbal balik hasil besar bersama https://kdwapp.com/
akun demo slot permainan paling high dan garansi imbal balik hasil besar bersama https://kdwapp.com/
slot demo gacor
akun demo slot gacor
akun slot demo gacor
akun demo slot pragmatic
akun slot demo pragmatic
akun slot demo
akun demo slot
slot demo gacor permainan paling high dan garansi imbal balik hasil besar bersama https://jebswagstore.com
akun demo slot gacor permainan paling high dan garansi imbal balik hasil besar bersama https://jebswagstore.com
akun slot demo gacor permainan paling high dan garansi imbal balik hasil besar bersama https://jebswagstore.com
akun demo slot pragmatic permainan paling high dan garansi imbal balik hasil besar bersama https://jebswagstore.com
akun slot demo pragmatic permainan paling high dan garansi imbal balik hasil besar bersama https://jebswagstore.com
akun slot demo permainan paling high dan garansi imbal balik hasil besar bersama https://jebswagstore.com
akun demo slot permainan paling high dan garansi imbal balik hasil besar bersama https://jebswagstore.com
slot demo gacor
akun demo slot gacor
akun slot demo gacor
akun demo slot pragmatic
akun slot demo pragmatic
akun slot demo
akun demo slot
slot demo gacor permainan paling high dan garansi imbal balik hasil besar bersama https://demoslotgacor.professional
akun demo slot gacor permainan paling high dan garansi imbal balik hasil besar bersama https://demoslotgacor.professional
akun slot demo gacor permainan paling high dan garansi imbal balik hasil besar bersama https://demoslotgacor.professional
akun demo slot pragmatic permainan paling high dan garansi imbal balik hasil besar bersama https://demoslotgacor.professional
akun slot demo pragmatic permainan paling high dan garansi imbal balik hasil besar bersama https://demoslotgacor.professional
akun slot demo permainan paling high dan garansi imbal balik hasil besar bersama https://demoslotgacor.professional
akun demo slot permainan paling high dan garansi imbal balik hasil besar bersama https://demoslotgacor.professional
slot demo gacor
akun demo slot gacor
akun slot demo gacor
akun demo slot pragmatic
akun slot demo pragmatic
akun slot demo
akun demo slot
slot demo gacor permainan paling high dan garansi imbal balik hasil besar bersama https://situsslotterbaru.web
akun demo slot gacor permainan paling high dan garansi imbal balik hasil besar bersama https://situsslotterbaru.web
akun slot demo gacor permainan paling high dan garansi imbal balik hasil besar bersama https://situsslotterbaru.web
akun demo slot pragmatic permainan paling high dan garansi imbal balik hasil besar bersama https://situsslotterbaru.web
akun slot demo pragmatic permainan paling high dan garansi imbal balik hasil besar bersama https://situsslotterbaru.web
akun slot demo permainan paling high dan garansi imbal balik hasil besar bersama https://situsslotterbaru.web
akun demo slot permainan paling high dan garansi imbal balik hasil besar bersama https://situsslotterbaru.web
slot demo gacor
akun demo slot gacor
akun slot demo gacor
akun demo slot pragmatic
akun slot demo pragmatic
akun slot demo
akun demo slot
situs slot terbaru
slot terbaru